Profile | GDS4284 / 213156_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2692.21 | 87 |
GSM687648 | Patient 402 control | 1547.41 | 80 |
GSM687653 | Patient 403 control | 6806.78 | 95 |
GSM687658 | Patient 404 control | 2027.03 | 84 |
GSM687663 | Patient 411 control | 6371.78 | 95 |
GSM687668 | Patient 422 control | 2994.46 | 89 |
GSM687673 | Patient 424 control | 1483.27 | 80 |
GSM687678 | Patient 425 control | 1690.35 | 81 |
GSM687683 | Patient 427 control | 2299.66 | 86 |
GSM687688 | Patient 428 control | 3457.65 | 90 |
GSM687695 | Patient 441 control | 542.373 | 63 |
GSM687699 | Patient 443 control | 1990.63 | 84 |
GSM687704 | Patient 444 control | 5532.52 | 94 |
GSM687707 | Patient 448 control | 1177.65 | 77 |
GSM687712 | Patient 449 control | 1541.8 | 80 |
GSM687719 | Patient 450 control | 1133.66 | 76 |
GSM687724 | Patient 451 control | 1581.14 | 81 |
GSM687728 | Patient 452 control | 1390.74 | 79 |
GSM687646 | Patient 401 treated 24h | 1880.6 | 83 |
GSM687649 | Patient 402 treated 24h | 2448.11 | 86 |
GSM687665 | Patient 411 treated 24h | 5909.33 | 95 |
GSM687651 | Patient 402 treated 4 weeks | 1844.59 | 83 |
GSM687667 | Patient 411 treated 4 weeks | 5531.81 | 94 |
GSM687670 | Patient 422 treated 24h | 3084.65 | 89 |
GSM687671 | Patient 422 treated 4 weeks | 2765.59 | 88 |
GSM687654 | Patient 403 treated 24h | 7473.14 | 96 |
GSM687675 | Patient 424 treated 24h | 1553.83 | 80 |
GSM687685 | Patient 427 treated 24h | 2144.74 | 85 |
GSM687656 | Patient 403 treated 4 weeks | 6795.56 | 95 |
GSM687677 | Patient 424 treated 4 weeks | 2323.32 | 86 |
GSM687687 | Patient 427 treated 4 weeks | 1956.58 | 83 |
GSM687692 | Patient 428 treated 4h | 3592.16 | 90 |
GSM687716 | Patient 449 treated 4h | 1884.82 | 83 |
GSM687722 | Patient 450 treated 4h | 1259.52 | 78 |
GSM687680 | Patient 425 treated 24h | 1933.47 | 83 |
GSM687690 | Patient 428 treated 24h | 3746.86 | 91 |
GSM687700 | Patient 443 treated 24h | 1332.88 | 78 |
GSM687705 | Patient 444 treated 24h | 6386.8 | 95 |
GSM687714 | Patient 449 treated 24h | 1466.66 | 80 |
GSM687721 | Patient 450 treated 24h | 775.143 | 70 |
GSM687682 | Patient 425 treated 4 weeks | 2367.87 | 86 |
GSM687694 | Patient 428 treated 4 weeks | 3874.38 | 91 |
GSM687702 | Patient 443 treated 4 weeks | 2212.07 | 85 |
GSM687718 | Patient 449 treated 4 weeks | 2740.58 | 88 |
GSM687723 | Patient 450 treated 4 weeks | 1572.6 | 81 |
GSM687661 | Patient 404 treated 4h | 2140.69 | 85 |
GSM687710 | Patient 448 treated 4h | 1721.72 | 82 |
GSM687726 | Patient 451 treated 4h | 1807.88 | 83 |
GSM687730 | Patient 452 treated 4h | 1307.53 | 79 |
GSM687660 | Patient 404 treated 24h | 1791.35 | 84 |
GSM687697 | Patient 441 treated 24h | 983.557 | 74 |
GSM687709 | Patient 448 treated 24h | 1221.08 | 77 |
GSM687725 | Patient 451 treated 24h | 1647.01 | 82 |
GSM687729 | Patient 452 treated 24h | 852.118 | 73 |
GSM687727 | Patient 451 treated 4 weeks | 2441.41 | 87 |
GSM687731 | Patient 452 treated 4 weeks | 1313.75 | 78 |